Once a "virtual company", it has grown over a decade into the most international force in stem cells

Article Abstract:

Stem Cell Sciences (SCS) is the most global of any stem cell company having corporate research and development centers in the UK, Japan, and Australia. SCS, set up by Peter Mountford, chief executive of SCS in his native Australia as a 'Virtual company' in the year 1994 is further planning to set up a US operation in the year 2005.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

The former patent powerhouse works on new therapies

Article Abstract:

California-based Geron Company was founded in 1992 as one of the first public companies to study embryonic stem cells. Geron is pursuing research in a wide number of disease areas, including Parkinson's, heart disease, diabetes, arthritis, blood disease, osteoporosis, and organ transplantation.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Tough cell to investors

Article Abstract:

Venture capitalists totally understand the rich potential of stem cells, although many reasons make them hesitate to invest. Even though stem cells have the potential to provide therapies for a huge range of ills, it is proving hard to attract the investment needed to develop them.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: